This compound is an organic molecule featuring a quinoxaline ring system linked to a dihydroimidazole group. It is primarily supplied as an active pharmaceutical ingredient for use in pharmaceutical manufacturing and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 91147-43-2
Terbinafine
pharmaceutical raw material
Gemigliptin
pharmaceutical raw material
Noscapine hydrochloride
pharmaceutical raw material
N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-amido}cyclohexyl]ethanediamide
pharmaceutical raw material
Brimonidine
pharmaceutical raw material
Brimonidine D-tartrate
pharmaceutical raw material
Brimonidine tartrate
pharmaceutical raw material
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
PVKUNRLEOHFACD-UHFFFAOYSA-N
C1CN=C(N1)NC2=CC3=NC=CN=C3C=C2